Multimodal treatment of unresectable hepatocellular carcinoma to achieve complete response results in improved survival

Publisher： John Wiley & Sons Inc

E-ISSN： 1477-2574|17|5|454-460

ISSN： 1365-182x

Source： HPB, Vol.17, Iss.5, 2015-05, pp. : 454-460

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modified cisplatin/interferon α‐2b/doxorubicin/5‐fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma

By  

CANCER, Vol. 119, Iss. 18, 2013-09 ,pp. : 3334-3342

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multimodal Treatment of Hepatocellular Carcinoma (HCC)

By  

Oncology Research and Treatment, Vol. 27, Iss. 3, 2004-07 ,pp. : 294-303

Karger

Access to resources Recommend Favorite

Chemoembolization for Unresectable Hepatocellular Carcinoma in Japan

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 135-141

Karger

Access to resources Recommend Favorite

Complete Response after Short-Term Sorafenib Treatment in a Patient with Lymph Node Metastasis of Hepatocellular Carcinoma

By  

Case Reports in Oncology, Vol. 5, Iss. 2, 2012-07 ,pp. : 380-384

Karger

Access to resources Recommend Favorite

Initial Treatment Response Is Essential to Improve Survival in Patients with Hepatocellular Carcinoma Who Underwent Curative Radiofrequency Ablation Therapy

By  

Oncology, Vol. 72, Iss. 1, 2007-12 ,pp. : 98-103

Karger

Access to resources Recommend Favorite